16 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

OneStim-DUO Cardiac Stimulator (MP5003-4CO)

FDA 510(k)
FDA Class 2 ·Cardiovascular

AXIOS Stent with Delivery System, AXIOS Stent with Electro-cautery Enhanced Delivery System

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

SLACTIVE IMPLANTS

FDA 510(k)
FDA Class 2 ·Dental

AXIOS

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC CORPORATION·Product code KNS·December 18, 2024

AXIOS

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC CORPORATION·Product code KNS·February 19, 2025

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·September 10, 2025

AXIOS

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC CORPORATION·Product code KNS·December 17, 2024

AXIOS

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC CORPORATION·Product code KNS·February 20, 2025

AXIOS

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC CORPORATION·Product code KNS·December 18, 2024

GE OEC 2600

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS INC.·Product code JAA·December 9, 2008

TRANSTAR STRETCHER

FDA Adverse Event
Malfunction ·HILL-ROM, INC.·Product code FPO·August 31, 2011

DIMENSION RXL MAX WITH HM

FDA Adverse Event
Malfunction ·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Product code MMI·July 29, 2013

PERCLOSE PROGLIDE¿

FDA Adverse Event
Injury ·ABBOTT VASCULAR INC.·Product code MGB·July 14, 2025

AXIOS?

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC CORPORATION·Product code KNS·December 18, 2024

AXIOS

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC CORPORATION·Product code KNS·November 27, 2024

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014